Effect of miR-205 on 3T3-L1 preadipocyte differentiation through targeting to glycogen synthase kinase 3 beta

Biotechnology Letters

Volumn 36, Issue 6, 2014, Pages 1233-1243

  Yu, Jingwei ^a   Chen, Yaosheng ^a   Qin, Limei ^a   Cheng, Luxi ^a   Ren, Guangcai ^a   Cong, Peiqing ^a   Mo, Delin ^a   He, Zuyong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Adipogenesis; Glycogen synthase kinase (GSK 3 ); LNA antimiR; MiR 205; Preadipocytes proliferation; Wnt signaling pathway

Indexed keywords

CELL PROLIFERATION; CYTOLOGY; ENZYMES; MAMMALS; NUCLEIC ACIDS; OLIGONUCLEOTIDES; TISSUE; TRANSCRIPTION;

ADIPOGENESIS; GLYCOGEN SYNTHASE KINASE; LNA-ANTIMIR; MIR-205; PREADIPOCYTES; WNT SIGNALING PATHWAYS;

CELL SIGNALING;

MUS;

GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MICRORNA; MIRN205 MICRORNA, MOUSE;

3T3 CELL LINE; ADIPOCYTE; ANIMAL; ANIMAL EXPERIMENT; BIOSYNTHESIS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; STEM CELL;

3T3-L1 CELLS; ADIPOCYTES; ANIMAL EXPERIMENTATION; ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; MICE; MICRORNAS; STEM CELLS;

EID: 84899990766     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-014-1491-8     Document Type: Article

References (25)

1. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD, MacDougald OA (2002) Regulation of Wnt signaling during adipogenesis. J Biol Chem 277: 30998-31004.
3. Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A (2009) Adipogenesis and WNT signaling. Trends Endocrinol Metab 20: 16-24.
4. Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M (2011) miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem 286: 16606-16614.
5. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli G (2009) The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16: 1590-1598.
6. Guo Y, Mo D, Zhang Y, Zhang Y, Cong P, Xiao S, He Z, Liu X, Chen Y (2012) MicroRNAome comparison between intramuscular and subcutaneous vascular stem cell adipogenesis. PLoS ONE 7: e45410.
7. Hagman Z, Haflidadottir BS, Ceder JA, Larne O, Bjartell A, Lilja H, Edsjo A, Ceder Y (2013) miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. Br J Cancer 108: 1668-1676.
8. Hornstein E, Shomron N (2006) Canalization of development by microRNAs. Nat Genet 38: S20-S24.
9. John E, Wienecke-Baldacchino A, Liivrand M, Heinäniemi M, Carlberg C, Sinkkonen L (2012) Dataset integration identifies transcriptional regulation of microRNA genes by PPARγ in differentiating mouse 3T3-L1 adipocytes. Nucleic Acids Res 40: 4446-4460.
10. Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, Lee YS, Kim JB (2010) miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 392: 323-328.
11. Li Y-J, Wei Z-M, Meng Y-X, Ji X-R (2005) b-Catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis. World J Gastroenterol 11: 2117-2123.
12. Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
13. Majid S, Saini S, Dar AA, Hirata H, Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, Chang I, Deng G, Dahiya R (2011) MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res 71: 2611-2621.
14. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J Am Med Assn 289: 76-79.
15. Moldes M, Zuo Y, Morrison R, Silva D, Park B, Liu J, Farmer S (2003) Peroxisome-proliferator-activated receptor γ suppresses Wnt/β-catenin signaling during adipogenesis. Biochem J 376: 607-613.
16. Muratsu-Ikeda S, Nangaku M, Ikeda Y, Tanaka T, Wada T, Inagi R (2012) Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells. PLoS ONE 7: e41462.
17. Park CY, Choi YS, McManus MT (2010) Analysis of microRNA knockouts in mice. Hum Mol Genet 19: R169-R175.
18. Qin L, Chen Y, Niu Y, Chen W, Wang Q, Xiao S, Li A, Xie Y, Li J, Zhao X, He Z, Mo D (2010) A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway. BMC Genom 11: 320.
19. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA (2000) Inhibition of adipogenesis by Wnt signaling. Science 289: 950-953.
20. Takahashi-Yanaga F, Sasaguri T (2008) GSK-3β regulates cyclin D1 expression: a new target for chemotherapy. Cell Signal 20: 581-589.
21. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, Croce CM, Guttridge DC (2008a) NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14: 369-381.
22. Wang Q, Li YC, Wang J, Kong J, Qi Y, Quigg RJ, Li X (2008b) miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc Natl Acad Sci USA 105: 2889-2894.
23. Xin M, Small EM, Sutherland LB, Qi XX, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, Olson EN (2009) MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Gene Dev 23: 2166-2178.
24. Yi C, Xie WD, Li F, Lv Q, He J, Wu J, Gu D, Xu N, Zhang Y (2011) MiR-143 enhances adipogenic differentiation of 3T3-L1 cells through targeting the coding region of mouse pleiotrophin. FEBS Lett 585: 3303-3309.
25. Zeng C, Wang R, Li D, Lin XJ, Wei QK, Yuan Y, Wang Q, Chen W, Zhuang SM (2010) A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology 52: 1702-1712.